Recovery of locomotor function with combinatory drug treatments designed to synergistically activate specific neuronal networks

Current Medicinal Chemistry

Volumn 16, Issue 11, 2009, Pages 1366-1371

  Guertin, Pierre A ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Central pattern generator; CPG; Dopamine; L DOPA; Locomotion; Mice; SCI; Serotonin; Spinal cord

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; 4 AMINOPYRIDINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ATI 355; BACLOFEN; BUSPIRONE; CETHRIN; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GLATIRAMER; LEVODOPA; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID; QUIPAZINE; RECEPTOR BLOCKING AGENT; RHO KINASE INHIBITOR; RILUZOLE; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SR 57277A; TIZANIDINE; UNCLASSIFIED DRUG;

CONVALESCENCE; DECOMPRESSION SURGERY; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESEARCH; DRUG SAFETY; HUMAN; LEG MOVEMENT; LOCOMOTION; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NERVE CELL NETWORK; NONHUMAN; PHYSIOTHERAPY; RECEPTOR UPREGULATION; REVIEW; SENSORY DYSFUNCTION; SPINAL CORD INJURY; SPINAL CORD SURGERY; STEM CELL TRANSPLANTATION; TREADMILL EXERCISE; WEIGHT BEARING;

ANIMALS; DOPAMINE; DOPAMINE AGONISTS; DRUG SYNERGISM; HUMANS; LEVODOPA; LOCOMOTION; REHABILITATION; SEROTONIN; SEROTONIN AGONISTS; SPINAL CORD INJURIES;

EID: 65649118957     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787846541     Document Type: Review

References (64)

1. Kalat, J.W. Biological Psychology, 6th Edition, Pacific Grove, CA Brooks/Cole, 1998.
2. Kandel, E.R.; Schwartz, J.H.; Jessell, T.M. Principles of neural science, 4th Edition, McGraw-Hill, New York, 2000.
3. www.icord.org (source: Canadian Paraplegic Association).
4. www.spinalcord.org (source: The National Spinal Cord Injury Association).
5. www.wrongdiagnosis.com.
6. Baptiste, D.C.; Fehlings, M.G. Update on the treatment of spinal cord injury. Prog. Brain Res., 2007, 161, 217-33.
7. Anderson, K.D. Targeting recovery: priorities of the spinal cordinjured population. J. Neurotrauma, 2004, 21, 1371-83
8. Anderson, K.D.; Borisoff, J.F.; Johnson, R.D.; Stiens, S.A.; Elliott, S.L. The impact of spinal cord injury on sexual function: concerns of the general population. Spinal cord, 2007, 45, 328-37.
9. Bauman, W.A.; Kahn, N.N.; Grimm, D.R.; Spungen, A.M. Risk factors for artherogenesis and cardiovascular autonomic function in persons with SCI. Spinal Cord, 1999, 37, 601-16.
10. Bauman, W.A.; Spungen, A.M. Metabolic changes in persons after SCI. Phys. Med. Rehab. Clin. N. Am., 2000, 11, 109-40.
11. Cruse, J.M.; Lewis, R.E.; Dilioglou, S.; Roe, D.L.; Wallace, W.F.; Chen, R.S. Review of immune function, healing of pressure ulcers, and nutritional status in patients with SCI. J. Spinal Cord Med., 2000, 23, 129-35.
12. Barbeau, H.; Chau, C.; Rossignol, S. Noradrenergic agonists and locomotor training affect locomotor recovery after cord transection in adult cats. Brain Res Bull., 1993, 30, 387-93.
13. Protas, E.J.; Holmes, S.A.; Qureshy, H.; Johnson, A.; Lee, D.; Sherwood, A.M. Supported treadmill ambulation training after spinal cord injury: a pilot study. Arch. Phys. Med. Rehabil., 2001, 82, 825-31.
14. Wernig, A.; Muller, S. Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries. Paraplegia, 1992, 30, 229-38.
15. Wernig, A.; Muler, S.; Nanassy, A.; Cagol, E. Laufband therapy based on 'rules of spinal locomotion' is effective in spinal cord injured persons. Eur. J. Neurosci., 1995, 7, 823-9.
16. Wernig, A.; Nanassy, A.; Muller, S. Laufband (treadmill) therapy in incomplete paraplegia and tetraplegia. J. Neurotrauma., 1999, 16, 719-26.
17. Barbeau, H.; Norman, K.; Fung, J.; Visintin, M.; Ladouceur, M. http://www.ncbi.nlm.nih.gov/pubmed/ 9928326?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum Does neurorehabilitation play a role in the recovery of walking in neurological populations? Ann. N. Y. Acad. Sci., 1998, 860, 377-92.
18. Jewish Hospital & St-Mary's HealthCare website (www.jewishhospital. org/carecenters/Spinal/re∑↗uro.asp)
19. Vergano, D.; Minzesheimer, B. Rehabilitation eases Reeve's paralysis. USA Today, 2002, (www.usatoday.com/life/ 2002-09-11-reeve_x.htm).
20. Grillner S, Zangger P (1979) On the central generation of locomotion in the low spinal cat. Exp Brain Res. 34(2):241-61.
21. Sherrington, C.S. Flexion-reflex of the limb, crossed extension reflex, and reflex stepping and standing. J. Physiol. (London), 1910, 40, 28-121.
22. Graham Brown, T. On the fundamental activity of the nervous centres: together with an analysis of the conditioning of rhythmic activity in progression, and a theory of the evolution of function in the nervous system. J. Physiol., 1914, 48, 18-41.
23. Viala, D.; Buser, P. Modalités d'obtention de rythmes locomoteurs chez le lapin spinal par traitements pharmacologiques (DOPA, 5-HTP, D-amphétamine). Brain Res, 1971, 35, 151-165.
24. Barbeau, H.; Rossignol, S. The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat. Brain Res., 1990, 514, 55-67.
25. Kjaerulff, O.; Barajon, I.; Kiehn, O., Sulphorhodamine-labelled cells in the neonatal rat spinal cord following chemically induced locomotor activity in vitro. J. Physiol. 1994, 478, 265-73.
26. Cina, C.; Hochman, S. Diffuse distribution of sulforhodaminelabeled neurons during serotonin-evoked locomotion in the neonatal rat thoracolumbar spinal cord. J. Comp. Neurol., 2000, 423, 590-602.
27. Nishimaru, H.; Takizawa, H.; Kudo, N. 5-Hydroxytryptamineinduced locomotor rhythm in the neonatal mouse spinal cord in vitro. Neurosci. Lett., 2000, 280, 187-90.
28. Dimitrijevic, M.R.; Gerasimenko, Y.; Pinter, M.M. Evidence for a spinal central pattern generator in humans. Ann. N.Y. Acad. Sci., 1998, 860, 377-92.
29. Guertin, P.; Angel, M.J.; Perreault, M.C.; McCrea, D.A. Ankle extensor group I afferents excite extensors throughout the hindlimb during fictive locomotion in the cat. J. Physiol.,1995, 487, 197-209.
30. Angel, M.J.; Guertin, P.; Jimenez, I.; McCrea, D.A. Group I extensor afferents evoke disynaptic EPSPs in cat hindlimb extensor motorneurones during fictive locomotion. J. Physiol., 1996, 494, 851-61.
31. Whelan, P.J., Hiebert, G.W., Pearson, K.G. Stimulation of the group I extensor afferents prolongs the stance phase in walking cats. Exp. Brain Res., 1995, 103, 20-30.
32. Guertin, P.A. A technological platform to optimize combinatorial treatment design and discovery for chronic spinal cord injury. J. Neurosci. Res., 2008, 86, 3039-51.
33. Guertin, P.A. Semiquantitative assessment of hindlimb movement recovery without intervention in adult paraplegic mice. Spinal Cord, 2005, 43, 162-6.
34. Landry, E.S.; Guertin, P.A. Differential effects of 5-HT1 and 5-HT2 receptor agonists on hindlimb movements in paraplegic mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2004, 28, 1053-60.
35. Landry, E.S.; Lapointe, N.P.; Rouillard, C.; Levesque, D.; Hedlund, P.B.; Guertin, P.A. Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice. Eur. J. Neurosci., 2006, 24, 535-46.
36. Guertin, P.; Steuer, I. Ionotropic 5-HT3 receptor agonist-induced motor responses in the hindlimbs of paraplegic mice. J. Neurophysiol., 2005, 594, 3397-405.
37. Guertin, P.A. Role of NMDA receptor activation in serotonin agonist-induced air-stepping in paraplegic mice. Spinal Cord, 2004, 42, 185-90.
38. Lapointe, N.P.; Ung, R.V.; Rouleau, P.; Guertin, P.A. Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice. J. Pharmacol. Exp. Ther., 2008, 325, 994-1006.
39. Lapointe, N.P.; Guertin, P.A. Synergistic effects of D1/5 and 5-HT1A/7 receptor agonists on locomotor movement induction in complete spinal cord-transected mice. J. Neurophysiol., 2008, 100, 160-8.
40. Guertin, P.A. Synergistic activation of the central pattern generator for locomotion by l-beta-3,4-dihydroxyphenylalanine and quipazine in adult paraplegic mice. Neurosci. Lett., 2004, 358, 71-4.
41. Jiang, Z.; Carlin, K.P.; Brownstone, R.M. An in vitro functionally mature mouse spinal cord preparation for the study of spinal motor networks. Brain Res., 1999, 816, 493-9.
42. Whelan, P.; Bonnot, A.; O'Donovan, M.J. Properties of rhythmic activity generated by the isolated spinal cord of the neonatal mouse. J. Neurophysiol., 2000, 84, 2821-33.
43. Guertin, P.; Brochu, C. Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient. Spinal Cord, 2008, (Epub ahead of print).
44. Barnes, N.M.; Sharp, T. A review of central 5-HT receptors and their function. Neuropharmacology, 1999, 38, 1083-152.
45. Hoyer, D.; Hannon, J.P.; Martin, G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav., 2002, 71, 533-54.
46. Schmidt, B.J.; Jordan, L.M. The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord. Brain Res. Bull., 2000, 53, 689-710.
47. Antri, M.; Barthe, J.Y.; Mouffle, C.; Orsal, D. Long-lasting recovery of locomotor function in chronic spinal rat following chronic combined pharmacological stimulation of serotonergic receptors with 8-OHDPAT and quipazine. Neurosci. Lett., 2005, 384, 162-7.
48. + channels. J. Neurosci. Res., 2004, 78, 845-54.
49. Perrier, J.F.; Alaburda, A.; Hounsgaard, J. 5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle. J. Physiol., 2003, 548, 485-92.
50. Cook, E.H.; Fletcher, K.E.; Wainwright, M.; Marks, N.; Yan, S.Y.; Leventhal, B.L. Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. J. Neurochem., 1994, 63, 465-9.
51. Shi, J.; Damjanoska, K.J.; Singh, R.K.; Carrasco, G.A.; Garcia, F.; Grippo, A.J.; Landry, M.; Sullivan, N.R.; Battaglia, G.; Muma, N.A. Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors. J. Pharmacol. Exp. Ther., 2007, 323, 248-56.
52. Kurrasch-orbaugh, D.M.; Parrish, J.C.; Watts, V.J.; Nichols, D.E. A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J. Neurochem., 2003, 86, 980-91.
53. Bartrup, J.T.; Newberry, N.R. 5-HT2A receptor-mediated outward current in C6 glioma cells is mimicked by intracellular IP3 release. Neuroreport, 1994, 5, 1245-8.
54. Parrish, J.C.; Nichols, D.E. erotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase cdependent mechanism. J. Neurochem., 2006, 99, 1164-75.
55. Johnson-Farley, N.N.; Kertesy, S.B.; Dubyak, G.R.; Cowen, D.S. Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells. J. Neurochem., 2005, 92, 72-82.
56. Garcia, M.C.; Kim, H.Y. Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells. Brain Res., 1997, 768, 43-8.
57. Zhu, H.; Clemens, S.; Sawchuk, M.; Hochman, S. Expression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study. Neuroscience, 2007, 149, 885-97.
58. Lapointe, N.P.; Rouleau, P.; Rouillard, C.; Guertin, P.A. J. Neurosci., 2008 (submitted).
59. Gingrich, J.A.; Dearry, A.; Falardeau, P.; Bates, M.D.; Fremeau, R.T.; Caron, M.G. Location and molecular cloning of D1 dopamine receptor. Neurochem. Int., 1992, 20 Suppl:9S-15S.
60. Dai, R.; Ali, M.K.; Lezcano, N.; Bergson, C. A crucial role for cAMP and protein kinase A in D1 dopamine receptor regulated intracellular calcium transients. Neurosignals, 2008, 16, 112-23.
61. Han, J.Y.; Heo, J.S.; Lee, Y.J.; Lee, J.H.; Taub, M.; Han, H.J. Dopamine stimulates 45Ca2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells. J. Cell Physiol., 2007, 211, 486-94.
62. Gresch, P.J.; Walker, P.D. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat. Brain Res. Mol. Brain Res., 1999, 70, 125-34.
63. Blaazer, A.R.; Smid, P.; Kruse, C.G. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors. ChemMedChem, 2008, 3, 1299-309.
64. Zhang, J.; Xiong, B.; Zhen, X.; Zhang, A. Dopamine D1 receptor ligands; where are we now and where are we going. Med. Res. Rev., 2009, 29, 272-94.